- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
38 result(s) found for: Doppler ultrasonography.
Displaying page 1 of 2.
EudraCT Number: 2007-000467-23 | Sponsor Protocol Number: 1 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||
Full Title: Maternal and fetal haemodynamic response to Nifedipine tocolysis in normotensive pregnant women. | ||||||||||||||||||||||||||||
Medical condition: A more detailed investigation of the haemodynamic effect on the mother and fetus of Nifedipine tocolysis . Tocolysis will be used to facilitate external cephalic version for breech presentation at ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000727-17 | Sponsor Protocol Number: 281274 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Hypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypert... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005471-15 | Sponsor Protocol Number: NZHD01 | Start Date*: 2006-03-27 |
Sponsor Name:University of Heidelberg | ||
Full Title: Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts chronic allograft nephropathy | ||
Medical condition: Chronic allograft nephropathy (CAN) represents the main cause of renal allograft loss after 1 yr of transplantation. The trial shall find a way for early diagnostics. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001935-23 | Sponsor Protocol Number: NZHD02 | Start Date*: 2006-10-17 |
Sponsor Name:University of Heidelberg | ||
Full Title: Real-time contrast-enhanced sonography of renal transplant recipients accurately predicts vascular allograft nephropathy | ||
Medical condition: Vascular allograft nephropathy represents the main cause of renal allograft loss after 1 yr of transplantation. The trial shall find a way for early diagnostics. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001472-18 | Sponsor Protocol Number: UDT-2/PHT | Start Date*: 2011-05-10 |
Sponsor Name:STZ 1172 Gesundheitsförderung und Stoffwechselforschung | ||
Full Title: Double-Blind, Randomised, Cross-Over, Placebo-Controlled, Single-Centre Phase IIa Clinical Study on the Influence of Udenafil on the Portal Flow in Cirrhotic Patients with Portal Hypertension | ||
Medical condition: Portal hypertension, liver cirrhosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003703-21 | Sponsor Protocol Number: 5802003 | Start Date*: 2005-01-28 |
Sponsor Name:Semmelweis University | ||
Full Title: The role of hyperhomocysteinemia in the genesis of atherothrombotic vascular disease | ||
Medical condition: Established cardiovascular disease with elevated levels of homocystein | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000486-31 | Sponsor Protocol Number: HD201 | Start Date*: 2015-05-27 |
Sponsor Name:Department of Anaesthesiology and Intensive Care, University of Tartu | ||
Full Title: The effect of milrinone on central and regional blood flow in preterm neonates undergoing patent ductus arteriosus ligation. | ||
Medical condition: Acute cardiorespiratory deterioration in preterm neonates 6-12 hours after open arterial duct ligation that is called post ligation cardiac syndrome (PLCS). | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: EE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002394-38 | Sponsor Protocol Number: CAIN457F2354 | Start Date*: 2016-05-11 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A 52-week, multicenter study to assess the time course of response to secukinumab on joint inflammation using Power Doppler ultrasonography in patients with active psoriatic arthritis | |||||||||||||
Medical condition: Psoriatic Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IE (Completed) ES (Completed) HU (Completed) BE (Completed) NO (Completed) FR (Completed) AT (Completed) NL (Completed) CZ (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004669-24 | Sponsor Protocol Number: 8103 | Start Date*: 2009-01-02 |
Sponsor Name:Research Innovation Services, University of Nottingham | ||
Full Title: Nitrous Oxide and Cerebral Autoregulation | ||
Medical condition: This study is being conducted to evaluate the effects of inhaled concentrations of 20%, 30% and 40% Nitrous Oxide on cerebral autoregulation in healthy volunteers using transcranial doppler ultraso... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001905-33 | Sponsor Protocol Number: FSJD-TRACIP-2017 | Start Date*: 2017-10-25 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
Full Title: TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN: RANDOMIZED CLINICAL TRIAL (TRACIP STUDY) | |||||||||||||
Medical condition: EARLY INTRAUTERINE GROWTH RESTRICTION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001579-40 | Sponsor Protocol Number: P04440 | Start Date*: 2007-04-02 | |||||||||||
Sponsor Name:Schering-Plough France | |||||||||||||
Full Title: Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with infliximab | |||||||||||||
Medical condition: Spondyloarthropathies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) ES (Completed) DK (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005333-39 | Sponsor Protocol Number: WS982821 | Start Date*: 2012-01-17 |
Sponsor Name:National and Kapodistrial University of Athens | ||
Full Title: The effects of acute sildenafil administration on inflammatory markers in patients with vasculogenic erectile dysfunction. | ||
Medical condition: vasculogenic erectile dysfunction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: GR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003887-39 | Sponsor Protocol Number: P1200_46 | Start Date*: 2020-10-29 |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Molecular effects of Apremilast (Otezal) in synovial biopsies of patients with psoriatic arthisis | ||
Medical condition: Psoriasis and Psoriatic Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001523-57 | Sponsor Protocol Number: IM101179 | Start Date*: 2011-06-10 | |||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | |||||||||||||
Full Title: Multicenter, Open-Label Study to Assess Early Response to Abatacept with Background Methotrexate Using Power Doppler Ultrasonography in Patients with Active Rheumatoid Arthritis and Inadequate Resp... | |||||||||||||
Medical condition: Adult subjects with active rheumatoid arthritis (RA) according to the American Rheumatism Association criteria for the classification of RA and with inadequate response to methotrexate | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) DK (Completed) FR (Completed) ES (Completed) GB (Completed) IT (Completed) HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000234-57 | Sponsor Protocol Number: allo-APZ2-DFU-II-01 | Start Date*: 2017-08-07 | |||||||||||
Sponsor Name:RHEACELL GmbH & Co. KG | |||||||||||||
Full Title: An interventional, multicenter, single arm, phase I/IIa clinical trial to investigate the efficacy and safety of allo-APZ2-DFU on wound healing of diabetic neuropathic ulcer (DFU). | |||||||||||||
Medical condition: Diabetic neuropathic ulcer (DFU) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001004-22 | Sponsor Protocol Number: CRH 06/374/M | Start Date*: 2008-07-09 | |||||||||||
Sponsor Name:Centre René Huguenin | |||||||||||||
Full Title: A multicentre phase II trial to determine the efficacy of the anti-tyrosine kinase sunitinib (SUTENT®) as second line therapy in patients with transitional cell carcinoma (TCC) of the urothelium wh... | |||||||||||||
Medical condition: Histologically proven advanced TCC (transitional cell carcinoma) of the urothelium | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000180-13 | Sponsor Protocol Number: HAT1 | Start Date*: 2015-04-22 |
Sponsor Name:Medisch Centrum Haaglanden | ||
Full Title: The value of a High-Volume Image-Guided Injections (HVIGI) in chronic midportion Achilles tendinopathy: a double-blind, placebo-controlled, randomised clinical trial | ||
Medical condition: Chronic midportion Achilles tendinopathy | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000687-33 | Sponsor Protocol Number: HOPE | Start Date*: 2015-11-18 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Randomized placebo-controlled trial to investigate clinical efficacy, anti-inflammatory properties and safety of prednisolone in hand osteoarthritis: a proof-of-concept study | ||
Medical condition: Hand osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003223-53 | Sponsor Protocol Number: AGO/2015/008 | Start Date*: 2015-12-01 |
Sponsor Name:Ghent University Hospital | ||
Full Title: RANKL-blockade for the treatment of erosive osteoarthritis (OA) of interphalangeal finger joints Randomized, double blind, placebo-controlled study to evaluate the efficacy of denosumab 60mg sc ... | ||
Medical condition: erosive osteoarthritis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003573-26 | Sponsor Protocol Number: TRAMAV02092019 | Start Date*: Information not available in EudraCT |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Monocentric pilot trial evaluating efficacy of Trametinib in Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated | ||
Medical condition: Arteriovenous Malformations that are refractory to standard treatments or for which standard treatment are contra-indicated | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
